These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 26446011)
81. Design and Feasibility of an Intervention to Support Cancer Genetic Counselees in Informing their At-Risk Relatives. de Geus E; Eijzenga W; Menko FH; Sijmons RH; de Haes HC; Aalfs CM; Smets EM J Genet Couns; 2016 Dec; 25(6):1179-1187. PubMed ID: 27103421 [TBL] [Abstract][Full Text] [Related]
82. Family communication matters: the impact of telling relatives about unclassified variants and uninformative DNA-test results. Vos J; Jansen AM; Menko F; van Asperen CJ; Stiggelbout AM; Tibben A Genet Med; 2011 Apr; 13(4):333-41. PubMed ID: 21358410 [TBL] [Abstract][Full Text] [Related]
83. Disclosure to the family of breast/ovarian cancer genetic test results: patient's willingness and associated factors. Julian-Reynier C; Eisinger F; Chabal F; Lasset C; Noguès C; Stoppa-Lyonnet D; Vennin P; Sobol H Am J Med Genet; 2000 Sep; 94(1):13-8. PubMed ID: 10982476 [TBL] [Abstract][Full Text] [Related]
84. Life events may contribute to family communication about cancer risk following BRCA1/2 testing. Lapointe J; Côté C; Bouchard K; Godard B; Simard J; Dorval M J Genet Couns; 2013 Apr; 22(2):249-57. PubMed ID: 22892900 [TBL] [Abstract][Full Text] [Related]
85. Risk communication in completed series of breast cancer genetic counseling visits. Pieterse AH; van Dulmen S; van Dijk S; Bensing JM; Ausems MG Genet Med; 2006 Nov; 8(11):688-96. PubMed ID: 17108760 [TBL] [Abstract][Full Text] [Related]
86. How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial. Eijzenga W; de Geus E; Aalfs CM; Menko FH; Sijmons RH; de Haes HCJM; Smets EMA Patient Educ Couns; 2018 Sep; 101(9):1611-1619. PubMed ID: 29789176 [TBL] [Abstract][Full Text] [Related]
87. Does and should breast cancer genetic counselling include lifestyle advice? Albada A; Vernooij M; van Osch L; Pijpe A; van Dulmen S; Ausems MG Fam Cancer; 2014 Mar; 13(1):35-44. PubMed ID: 23934600 [TBL] [Abstract][Full Text] [Related]
88. Disentangling the Babylonian speech confusion in genetic counseling: an analysis of the reliability and validity of the nomenclature for BRCA1/2 DNA-test results other than pathogenic. Vos J; van Asperen CJ; Wijnen JT; Stiggelbout AM; Tibben A Genet Med; 2009 Oct; 11(10):742-9. PubMed ID: 19745749 [TBL] [Abstract][Full Text] [Related]
89. Informing models of cancer genetics care in the era of multigene panel testing with patient-led recommendations. Underhill-Blazey M; Blonquist T; Chittenden A; Pozzar R; Nayak M; Lansang K; Hong F; Garber J; Stopfer JE J Genet Couns; 2021 Feb; 30(1):268-282. PubMed ID: 32851753 [TBL] [Abstract][Full Text] [Related]
90. Screening and genetic counselling for relatives of patients with breast cancer in a family cancer clinic. Houlston RS; Lemoine L; McCarter E; Harrington S; MacDermot K; Hinton J; Berger L; Slack J J Med Genet; 1992 Oct; 29(10):691-4. PubMed ID: 1433227 [TBL] [Abstract][Full Text] [Related]
91. Genetic counseling communication with an African American BRCA1 kindred. Ellington L; Maxwel A; Baty BJ; Roter D; Dudley WN; Kinney AY Soc Sci Med; 2007 Feb; 64(3):724-34. PubMed ID: 17081667 [TBL] [Abstract][Full Text] [Related]
92. Update on multi-gene panel testing and communication of genetic test results. Reid S; Pal T Breast J; 2020 Aug; 26(8):1513-1519. PubMed ID: 32639074 [TBL] [Abstract][Full Text] [Related]
93. Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study. Brédart A; De Pauw A; Tüchler A; Lakeman IMM; Anota A; Rhiem K; Schmutzler R; van Asperen CJ; Devilee P; Stoppa-Lyonnet D; Kop JL; Dolbeault S Clin Genet; 2022 Jul; 102(1):30-39. PubMed ID: 35508697 [TBL] [Abstract][Full Text] [Related]
94. Experiences of Family Communication and Cascade Genetic Testing for Hereditary Cancer in Medically Underserved Populations-A Qualitative Study. Bednar EM; Rauh-Hain JA; Garcia JJ; de Aguinaga N; Powell MA; Peral SL; Nitecki R; Jorgensen K; Rudy NL; Lu KH; Leath CA; Scarinci IC Cancer Prev Res (Phila); 2024 Jan; 17(1):19-28. PubMed ID: 37913800 [TBL] [Abstract][Full Text] [Related]
95. Using a state cancer registry to increase screening behaviors of sisters and daughters of breast cancer patients. Houts PS; Wojtkowiak SL; Simmonds MA; Weinberg GB; Heitjan DF Am J Public Health; 1991 Mar; 81(3):386-8. PubMed ID: 1994751 [TBL] [Abstract][Full Text] [Related]
96. Genetic Testing for Breast Cancer Patients: Is Everyone Who Needs a Test Getting a Test? Heller DR; Friedrich AU; Killelea BK Ann Surg Oncol; 2021 Jan; 28(1):18-19. PubMed ID: 33063259 [No Abstract] [Full Text] [Related]
97. Development of a plain-language guide for discussing breast cancer genetic counseling and testing with patients with limited health literacy. van der Giessen JAM; Ausems MGEM; van Riel E; de Jong A; Fransen MP; van Dulmen S Support Care Cancer; 2021 Jun; 29(6):2895-2905. PubMed ID: 33001269 [TBL] [Abstract][Full Text] [Related]
98. Is no news good news? Inconclusive genetic test results in BRCA1 and BRCA2 from patients and professionals' perspectives. Ardern-Jones A; Kenen R; Lynch E; Doherty R; Eeles R Hered Cancer Clin Pract; 2010 Jan; 8(1):1. PubMed ID: 20180951 [TBL] [Abstract][Full Text] [Related]
99. Patient Recall, Interpretation, and Perspective of an Inconclusive Long QT Syndrome Genetic Test Result. Predham S; Hathaway J; Hulait G; Arbour L; Lehman A J Genet Couns; 2017 Feb; 26(1):150-158. PubMed ID: 27369690 [TBL] [Abstract][Full Text] [Related]
100. Family communication following BRCA1/2 genetic testing: a close look at the process. Lafrenière D; Bouchard K; Godard B; Simard J; Dorval M J Genet Couns; 2013 Jun; 22(3):323-35. PubMed ID: 23242930 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]